Marco Capobianco

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

Sven Jarius, Klemens Ruprecht, Ingo Kleiter et al. · Journal of Neuroinflammation · 2016 · 891 citations · Full text

Medicine, Neurology, Neuroscience +15

Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

Maria Pia Sormani, Nicola De Rossi, Irene Schiavetti et al. · Annals of Neurology · 2021 · 461 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin

Sven Jarius, Klemens Ruprecht, Ingo Kleiter et al. · Journal of Neuroinflammation · 2016 · 428 citations · Full text

Medicine, Immunology, Neurology +16

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

Riccardo Saccardi, Tomáš Kozák, Chiara Bocelli‐Tyndall et al. · Multiple Sclerosis Journal · 2006 · 217 citations

Medicine, Hematology, Immunology +16

Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients

Antonio Bertolotto, Francesca Gilli, Arianna Sala et al. · Neurology · 2003 · 183 citations

Life Sciences, Immunology, Pharmacology +16